Evidence map›Paper›PMID 21992560›Full record

ArticleInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group2011

Role of Pluronic block copolymers in modulation of heat shock protein 70 expression.

Reshani H Perera, Tianyi M Krupka, Hanping Wu, Bryan Traughber, David Dremann, Ann-Marie Broome, Agata A Exner

Abstract read
In one paragraph

Article in International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Pluronics and MDR reversal: an update.Molecular pharmaceutics · 2014
    Review
  6. Article
  7. Can nanomedicines kill cancer stem cells?Advanced drug delivery reviews · 2013
    Review
  8. Article
  9. Ultrasound imaging beyond the vasculature with new generation contrast agents.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Reshani H PereraDepartment of Radiology, Case Western Reserve University , Cleveland, OH 44106-5056, USA.
Tianyi M Krupka
Hanping Wu
Bryan Traughber
David Dremann
Ann-Marie Broome
Agata A Exner
Case Western Reserve University · US

Funding

Sensitizer Delivery for Focused Hyperthermia Cancer TreatmentR01CA136857 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI EXNER, AGATA A · 2009 to 2013
$1.9M
Dual-Receptor Targeted Nanoparticles for Photodynamic Therapy of Brain CancerR01EB012099 · NIBIB · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BROOME, ANN-MARIE · 2010 to 2013
$1.3M
NCI NIH HHS R01 CA136857NCI NIH HHS R01CA136857NIBIB NIH HHS R01 EB012099
6 · The paper itself

Abstract

purposeThe goal of this study was to evaluate the relationship between previously demonstrated thermosensitising effects of the block copolymer, Pluronic, and heat shock protein 70 (Hsp70) expression in an experimental colorectal cancer model in vitro and in vivo. MATERIALS AND

methodsRat colorectal carcinoma cells were treated with low-grade hyperthermia (43°C) alone or in combination with Pluronics L10 (3 mg/mL), L61 (0.3 mg/mL), or L64 (0.5 mg/mL) for 20 min. Adinosine triphosphate (ATP) levels and cell viability were determined using standard assays. Hsp70 expression was quantified by western blot for cells treated with L10, L61, and L64 at doses specified above and Pluronic P85 (10 mg/mL) alone and in combination with heat. BDIX rats with flank tumours were used to study the effect of L61 and hyperthermia on Hsp70 expression in vivo.

resultsIn vitro, treatment with L10, L61, and L64 plus low-grade hyperthermia lead to depletion of ATP levels to between 8 and 66% of untreated control after 24 h. Maximum expression of Hsp70 was observed at 9 h following hyperthermia alone. The combination of low-grade hyperthermia and Pluronic treatment reduced Hsp70 expression for up to 6 hours, and L10 appeared to completely inhibit the Hsp70 expression. In vivo, Hsp70 expression was increased 5 h after hyperthermia in BDIX rat tumour models and no Hsp70 expression was observed in L61 pre-treated and control groups.

conclusionPluronic effectively improves hyperthermic and low-grade hyperthermic treatment in part due to reduction of Hsp70 expression.

Indexed as

AdenocarcinomaAnimalsCell Line, TumorCell ProliferationColorectal NeoplasmsHSP70 Heat-Shock ProteinsHyperthermia, InducedPoloxamerRatsHSP70 Heat-Shock ProteinsPoloxamer

Identifiers

PMID21992560
PMCPMC3294295
OpenAlexW2038261675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.